Work

Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease

Year: 2021

Type: article

Abstract: validation, we built a framework for predicting biomarkers and host-microbe interaction targets and identifying repurposing drugs for IBD, which may be tested further for clinical application. This approach may also be a tool for repurposing drugs for treating other diseases.

Source: Theranostics

DOI: 10.7150/thno.59196

Authors: Zhihan Wang, Kai Guo, Pan Gao, Qinqin Pu, Ping Lin, Shugang Qin, Na Xie, Junguk Hur, Changlong Li, Canhua Huang, Min Wu

Institutions: Sichuan University, University of North Dakota, University of Michigan, Wuhan University, Army Medical University, Daping Hospital, West China Hospital of Sichuan University, State Key Laboratory of Biotherapy

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,671

Funders: National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases

Awards: G1494934528, G2420143519, G3782466362, Dakota Cancer Collaborative on Translational Activity, Lung innate immunity against bacterial infection

OpenAlex ID: W3171363094

FWCI: 1.41

Cites: 75

Cited by: 41

Related to: 10